National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 679090

Case Details

VAERS ID: 679090 (history)  
Form: Version 1.0  
Age:   
Gender: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2017-01-23
Entered: 2017-01-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Unknown
Symptoms: Abdominal distension, Adverse event, Dizziness, Fatigue, Hypotension, Respiratory distress
SMQs:, Anaphylactic reaction (narrow), Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Acute central respiratory depression (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Vestibular disorders (broad), Hypersensitivity (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Childhood depression; Delivery
Allergies:
Diagnostic Lab Data:
CDC Split Type: DK0095075131612DNK004656

Write-up: Information has been received from the authors in published literature article titled as stated below. The aim of this study was to investigate HPV vaccinated women''s experiences with side effects caused by the HPV vaccine. Qualitative interviews were conducted with eight women, aged 25-44 years, who experienced side effects from vaccination against HPV. They were included in the study if aged 18 years or above and if they had received their HPV vaccination within the past three years. Adult women were chosen as a target group as they were believed to be more contemplative and reflective than young girls. This case concerns to a 28 year old female patient who was healthy and had signs of depression in childhood before vaccination. The patient was a early retired and has one child. On an unknown date, the patient received the first dose of unidentified Merck hpv vaccine administered (name not provided) (lot number, expiration date, dose, route, frequency and indication were unknown) for prophylaxis, because she had fear of cancer and she trusted in her physician. The fear of cancer was based on the women''s own risk perception, which could be influenced by their family history of cancer. On an unknown date, the patient received the second dose of unidentified Merck hpv vaccine administered (name not provided) (lot number, expiration date, dose, route, frequency and indication were unknown) and on an unspecified date in 2013 she received the third dose of unidentified Merck hpv vaccine administered (name not provided) (lot number, expiration date, dose, route, frequency and indication were unknown). On unknown date, the patient experienced an unspecified side effect from the vaccination with unidentified Merck hpv vaccine (name not provided) the time of the side effects was after the first injection and aggravated after the next injection (on an unknown date). The authors considered the side effect was related to the vaccination with unidentified Merck hpv vaccine (name and lot number not provided). Follow up information was received from the literature author entitled as stated below. In 2012, the patient was vaccinated with a dose of GARDASIL (site, route and lot number not reported) for prophylaxis. The author specified the adverse events experienced by the patient in 2012 were fatigue, dizziness, low blood pressure, cell changes, bloatedness (stomach) and respiratory distress. The outcome of fatigue, respiratory distress, abdominal distension, adverse event, hypotension and dizziness was unknown. Treatment included changed diet. In 2013, the patient received a dose of GARDASIL. The reporter considered cells change, respiratory distress, abdominal distension, hypotension and dizziness to be related to GARDASIL. The reporter considered fatigue, respiratory distress, abdominal distension, cells change, hypotension and dizziness serious as disability (also reported as "longer or permanent unfitness for work"). Upon internal review respiratory distress was considered serious as medically significant. This is one of several cases received from the same literature article (1612DNK004981, 1612DNK004588, 1612DNK004996, 1612DNK004841, 1612DNK004850, 1612DNK004650, 1612DNK004576). Additional information is not expected as author does not have additional information about the adverse events.; Sender''s Comments: DK-009507513-1612DNK004576: DK-009507513-1612DNK004588: DK-009507513-1612DNK004650: DK-009507513-1612DNK004841: DK-009507513-1612DNK004850: DK-009507513-1612DNK004981: DK-009507513-1612DNK004996:


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=679090


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166